Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion type Assertion NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_head.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion description "[In conclusion, TET2, DNMT3A and ASXL1 mutations are also present in mastocytosis and these mutations may affect prognosis, as demonstrated by worse OS in mutated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion evidence source_evidence_literature NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion SIO_000772 22905207 NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion wasDerivedFrom befree-2016 NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.
- NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_assertion wasGeneratedBy ECO_0000203 NP1006492.RABlG0X-3-uf_h3Q3R3j56hIn97cJBuuEdDFX8m8eHBeA130_provenance.